scispace - formally typeset
G

Gert A. Verpooten

Researcher at University of Antwerp

Publications -  74
Citations -  4270

Gert A. Verpooten is an academic researcher from University of Antwerp. The author has contributed to research in topics: Nephrotoxicity & Kidney. The author has an hindex of 32, co-authored 74 publications receiving 4078 citations. Previous affiliations of Gert A. Verpooten include Catholic University of Leuven & Rafael Advanced Defense Systems.

Papers
More filters
Journal ArticleDOI

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

TL;DR: MPA C predose and MPA AUC are significantly related to the incidence of biopsy-proven rejection after kidney transplantation, whereas MMF dose is significantly relatedto the occurrence of adverse events.
Journal ArticleDOI

The pharmacokinetic‐pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

TL;DR: Mycophenolate mofetil, a pro‐drug for mycophenolic acid, reduces the likelihood of allograft rejection after renal transplantation and is studied in a randomized concentration‐controlled trial.
Journal ArticleDOI

Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury

TL;DR: After severe warm I/R renal injury, a pronounced acute tubular necrosis occurs during the first 12-24 h in the absence of a marked cellular infiltrate, but with an important renal MPO activity, reflecting the activation of the adhering inflammatory cells (polymorphonuclear cells (PMNs) and mainly monocytes/macrophages).
Journal ArticleDOI

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.

TL;DR: The strong relationship existing between adherence to anti-osteoporosis treatment and the risk of subsequent hip fracture is related to the results confirm that adherence to current therapeutic regimens remains suboptimal.
Journal ArticleDOI

Once‐daily dosing decreases renal accumulation of gentamicin and netilmicin

TL;DR: For each aminoglycoside, a single short‐term infusion resulted in significantly lower renal drug levels than did a continuous infusion of the same dose, which supports the administration of gentamicin and netilmicin as once‐daily injections.